Matri Sys Bioscience reported raising $8.4 Million in an initial SEC Form D filing, from an offering of $61.7 Million
Round Type
Venture
La JollaBiotechnologyQuick answer
MatriSys Bioscience raised $8.4 Million in a funding round, dated July 15, 2022. MatriSys Bioscience is based in La Jolla, California, United States.
- How much did MatriSys Bioscience raise?
- MatriSys Bioscience raised $8.4 Million in a funding round on July 15, 2022.
- Where is MatriSys Bioscience based and how big is it?
- MatriSys Bioscience is based in La Jolla, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as MatriSys Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Anuva raised an undisclosed amount (Series A) on August 29, 2022.
- Lapix Therapeutics raised $1.2M (Seed) on August 29, 2022.
- Theranica raised $45M (Series C) on August 29, 2022.
- Anuncia Medical raised $999K (Seed) on August 26, 2022.
- Kolon TissueGene, Inc. raised $30M on August 26, 2022.
- Oasis Fertility raised $50M (Funding Round) on August 26, 2022.
Who to call at MatriSys Bioscience, and when
A new round usually means MatriSys Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MatriSys Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MatriSys Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MatriSys Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MatriSys Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MatriSys Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.